Please login to the form below
Teon Therapeutics
This page shows the latest Teon Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Cancer Research UK and Teon Therapeutics announce treatment of first patient in phase 1/2 trial for difficult-to-treat cancers
Cancer Research UK and Teon Therapeutics have announced that the first patient has been successfully dosed in their phase 1/2 trial of Teon’s first-in-class oral, once-daily ... Serge Messerlian, CEO of Teon Therapeutics, said: “As a daily, oral A2B
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Cuttsy + Cuttsy
Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
